TABLE 1. GLOBAL DIABETES THERAPEUTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL INJECTABLE DIABETES THERAPEUTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. DIABETES INJECTABLE THERAPEUTICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL OAD DIABETES THERAPEUTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 5. GLOBAL OAD DIABETES THERAPEUTICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. DIABETES THERAPEUTICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. NORTH AMERICA DIABETES THERAPEUTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 8. NORTH AMERICA DIABETES THERAPEUTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 9. EUROPE DIABETES THERAPEUTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. EUROPE DIABETES THERAPEUTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 11. ASIA-PACIFIC DIABETES THERAPEUTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 12. ASIA-PACIFIC DIABETES THERAPEUTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 13. LAMEA DIABETES THERAPEUTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 14. LAMEA DIABETES THERAPEUTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 15. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 16. BOEHRINGER: COMPANY SNAPSHOT
TABLE 17. ELI LILLY: COMPANY SNAPSHOT
TABLE 18. GLAXOSMITHKLINE: COMPANY SNAPSHOT
TABLE 19. J&J: COMPANY SNAPSHOT
TABLE 20. MERCK: COMPANY SNAPSHOT
TABLE 21. NOVARTIS: COMPANY SNAPSHOT
TABLE 22. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 23. SANOFI: COMPANY SNAPSHOT
TABLE 24. TAKEDA: COMPANY SNAPSHOT

LIST OF FIGURE

FIGURE 1. DIABETES THERAPEUTICS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, DIABETES THERAPEUTICS MARKET, 2016
FIGURE 9. IMPACT ANALYSIS: DIABETES THERAPEUTICS MARKET
FIGURE 10. TOTAL NUMBER OF CLINICAL TRIALS IN DIABETES THERAPEUTICS MARKET
FIGURE 11. INSULIN MARKET, 2016-2023, ($MILLION)
FIGURE 12. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS/INCRETIN MIMETICS MARKET, 2016-2023, ($MILLION)
FIGURE 13. AMYLIN ANALOGUE/AMYLINOMIMETIC DRUG MARKET, 2016-2023, ($MILLION)
FIGURE 14. BIGUANIDES MARKET, 2016-2023, ($MILLION)
FIGURE 15. SULFONYLUREAS MARKET, 2016-2023, ($MILLION)
FIGURE 16. THIAZOLIDINEDIONES MARKET, 2016-2023, ($MILLION)
FIGURE 17. ALPHA-GLUCOSIDASE INHIBITORS MARKET, 2016-2023, ($MILLION)
FIGURE 18. DIPEPTIDYL PEPTIDASE IV (DPP-4) INHIBITORS /GLIPTINS MARKET, 2016-2023, ($MILLION)
FIGURE 19. MEGLITINIDES MARKET, 2016-2023, ($MILLION)
FIGURE 20. SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS /GLIFLOZINS MARKET, 2016-2023, ($MILLION)
FIGURE 21. U.S. DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 22. CANADA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 23. MEXICO DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 24. GERMANY DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 25. FRANCE DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 26. UK DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 27. ITALY DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 28. SPAIN DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 29. REST OF EUROPE DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 30. JAPAN DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 31. CHINA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 32. INDIA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 33. AUSTRALIA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 34. SOUTH KOREA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 36. BRAZIL DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 37. SOUTH AFRICA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 38. SAUDI ARABIA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)
FIGURE 39. REST OF LAMEA DIABETES THERAPEUTICS MARKET, 2016-2023, ($MILLION)